Graham G. Walmsley

Average Profitability
20.1%
Insider Buys Quantity
17
Insider Buys Sum
$143.03M
Insider Sells Quantity
3
Insider Sells Sum
$26.91M

Insider Activity of Graham G. Walmsley

According to the SEC Form 4 filings, Graham G. Walmsley, being in a position of

  1. director at Akero Therapeutics, Inc.,
    оver the last 12 months, has bought 200000 shares for $9.6M, and sold 0 shares,
    over all time since 2022-09-19, has bought 1400000 shares for $42.53M, and sold 0 shares.

The largest purchase of all time was on 2020-11-23 and amounted to 2320000 shares of Olema Pharmaceuticals, Inc. for $44.08M.

The largest sale of all time was on 2024-06-04 and amounted to 1175000 shares of Olema Pharmaceuticals, Inc. for $17.45M.

Biography of Graham G. Walmsley

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$19,060,274350
Sells
$26,909,024350

Comparison of Insiders on Amount of Buys and Sells

2025-01-30PurchaseAkero Therapeutics, Inc.
AKRO
director
200,000
0.2547%
$48.00$9.6M-10.93%
2024-12-17SaleOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.3522%
$6.75$4.73M-12.21%
2024-12-17PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.3522%
$6.75$4.73M-12.21%
2024-12-13SaleOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.2508%
$6.75$4.73M-18.52%
2024-12-13PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
700,761
1.2508%
$6.75$4.73M-18.52%
2024-06-04SaleOlema Pharmaceuticals, Inc.
OLMA
director
1.18M
2.2298%
$14.85$17.45M-18.05%
2023-12-08PurchaseAkero Therapeutics, Inc.
AKRO
director
100,000
0.179%
$19.83$1.98M+22.32%
2023-12-05PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
131,870
0.2639%
$14.19$1.87M-8.37%
2023-12-01PurchaseAkero Therapeutics, Inc.
AKRO
director
50,000
0.0866%
$16.99$849,730+36.75%
2023-11-30PurchaseAkero Therapeutics, Inc.
AKRO
director
50,000
0.0904%
$16.90$844,835+44.15%
2023-09-19PurchaseAkero Therapeutics, Inc.
AKRO
director
400,000
0.5235%
$26.00$10.4M-55.44%
2023-09-12PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
508,130
1.0101%
$9.84$5M+1.96%
2023-08-08PurchaseAkero Therapeutics, Inc.
AKRO
director
25,000
0.0442%
$42.06$1.05M-46.77%
2023-08-01PurchaseAkero Therapeutics, Inc.
AKRO
director
25,000
0.0453%
$43.26$1.08M-48.03%
2023-07-28PurchaseAkero Therapeutics, Inc.
AKRO
director
30,000
0.0645%
$42.69$1.28M-46.22%
2023-05-19PurchaseAkero Therapeutics, Inc.
AKRO
director
120,000
0.2354%
$42.00$5.04M-47.25%
2022-09-19PurchaseAkero Therapeutics, Inc.
AKRO
director
400,000
0.9981%
$26.00$10.4M+66.05%
2020-12-14PurchaseALX Oncology Holdings Inc.
ALXO
director
40,000
0.1009%
$76.00$3.04M-20.73%
2020-11-23PurchaseOlema Pharmaceuticals, Inc.
OLMA
director
2.32M
4.1436%
$19.00$44.08M-44.3%
2020-07-21PurchaseALX Oncology Holdings Inc.
ALXO
director
1.95M
4.0591%
$19.00$37.05M+90.48%
Total: 20
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD